| Title | Author(s) | Year | View Count |
 | Demand uncertainty, Bayesian update, and IPO pricing | Qi, R; Zhou, X | 2011 | 77 |
 | Predicting Stock Market Returns with Aggregate Discretionary Accruals | Kang, Q; Liu, Q; Qi, R | 2010 | 42 |
| The Sarbanes-Oxley act and corporate investment: A structural assessment | Kang, Q; Liu, Q; Qi, R | 2010 | 126 |
 | Predict stock market returns with aggregate discretionary accruals | Kang, Q; Liu, Q; Qi, R | 2010 | 117 |
| Market timing with aggregate accruals | Kang, Q; Liu, Q; Qi, R | 2009 | 28 |
| Market timing strategy with aggregate accruals | Kang, Q; Liu, Q; Qi, R | 2009 | 100 |
| Stock trading and diversification discount | Liu, Q; Qi, R | 2008 | 90 |
| Divergent Opinions in the Pre-Issue Market and the Pricing of Initial Public Offerings | Qi, R; Zhou, X | 2008 | 117 |
| Divergent Opinions in the Pre-Issue Market and the Pricing of Initial Public Offerings | Qi, R; Zhou, X | 2008 | 143 |
| XIAP-associated factor 1 suppresses angiogenesis in mouse endothelial cells | Qiao, L; Gu, Q; Dai, Y; Shen, Z; Liu, XY; Qi, R; Ma, J; Zou, B; Lan, HY; Wong, BCY | 2008 | 107 |
| Market timing strategy with aggregate accruals | Liu, Q; Kang, Q; Qi, R | 2008 | 99 |
| XIAP-associated factor 1 (XAF1) suppresses angiogenesis in mouse endothelial cells | Qiao, L; Gu, Q; Dai, Y; Shen, Z; Liu, X; Qi, R; Ma, J; Zou, B; Li, Z; Lan, HY; Wong, BCY | 2008 | 75 |
| Potent antitumor efficacy of XAF1 delivered by conditionally replicative adenovirus vector via caspase-independent apoptosis | Qi, R; Gu, J; Zhang, Z; Yang, K; Li, B; Fan, J; Wang, C; He, Z; Qiao, L; Lin, Z; Liu, XY | 2007 | 157 |
| Information and accrual strategy: when do the markets mis-price accruals? | Liu, Q; Qi, R | 2006 | 138 |
| Predicting stock market return with aggregate (discretionary) accruals | Liu, Q; Kang, Q; Qi, R | 2006 | 111 |
| Predicting Stock Market Returns with Aggregate (discretionary) Accruals | Liu, Q; Kang, Q; Qi, R | 2006 | 126 |
| Do We Accept Accruals Profits At Our Peril? | Liu, Q; Qi, R | 2006 | 107 |
| Information Production, Cash Flow and Corporate Investment | Liu, Q; Qi, R | 2003 | 91 |
| Phosphoproteomic fingerprinting of growth factor signaling and anticancer drug action in human tumor cells. | Lim, YP; Diong, LS; Qi, R; Druker, BJ; Epstein, R | 2003 | 100 |
| Human breast and liver cancers are characterized by distinct phosphotyroproteomic signatures | Lim, YP; Diong, LS; Ooi, LL; Wong, BCY; Qi, R; Druker, BJ; Epstein, R | 2003 | 68 |
|
